Trials / Recruiting
RecruitingNCT06594913
Eating Disorders Genetics Initiative 2
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- University of North Carolina, Chapel Hill · Academic / Other
- Sex
- All
- Age
- 12 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new participants with anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), avoidant/restrictive food intake disorder (ARFID), and controls in the US, Mexico, Australia, New Zealand, Sweden, and Denmark. A primary study goal is to enroll at least 30% of participants from underrepresented groups. Participants are asked to complete a series of questionnaires and submit a saliva sample for genotyping. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Eating disorder diagnosis group | This is an observational study, no active intervention is applied. Participants are assigned to an eating disorder diagnosis group based on their lifetime history of disordered eating behaviors and symptoms. |
Timeline
- Start date
- 2024-10-28
- Primary completion
- 2027-08-01
- Completion
- 2027-08-01
- First posted
- 2024-09-19
- Last updated
- 2025-05-31
Locations
5 sites across 5 countries: United States, Australia, Mexico, New Zealand, Sweden
Source: ClinicalTrials.gov record NCT06594913. Inclusion in this directory is not an endorsement.